Adiposity‐related inflammation: Effects of pregnancy
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In the nonpregnant population, there is extensive evidence of a systemic low‐grade inflammatory status in relation to excess adipose tissue. Less is known about the relation during pregnancy. Objective: Our main objective was therefore to explore the effect of pregnancy on adiposity‐related systemic inflammation. Design and Methods: This study is a longitudinal cohort study of 240 pregnant women of Scandinavian heritage at Oslo University hospital—Rikshospitalet, Norway from 2002 to 2005. The inflammatory markers (C‐reactive protein [CRP], Interleukin‐6 [IL‐6], monocyte chemoattractant protein 1 [MCP‐1], IL1‐Ra, tumor necrosis factor receptor II, and IL‐10) were measured at four timepoints during pregnancy and analyzed by enzyme immuno‐assay. The women were categorized based on BMI at inclusion (BMI <25, 25–30, and >30 kg/m 2). Data were analyzed by Friedman‐test, Wilcoxon signed rank test, or Kruskal–Wallis test as appropriate. Results: Maternal adiposity was associated with significantly higher circulatory levels of several inflammatory markers (CRP, MCP‐1, IL‐6, and IL‐1Ra). However, this proinflammatory upregulation was not evident toward the end of pregnancy, as levels of CRP, MCP‐1, and IL‐6 were not any longer significantly different between the BMI categories. Conclusions: Although normal pregnancy exhibits proinflammatory features, this does not seem to have additive or synergistic effects on the inflammation associated with adiposity. On the contrary, we found that the BMI‐dependent increase in proinflammatory markers was not evident at the end of pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Is obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799
Cancello, R., & Clément, K. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01004.x · Cited by 418
Cited by
Catalano, P. M., & Shankar, K. (2017) · BMJ · doi:10.1136/bmj.j1 · Cited by 1,306
Inflammation in maternal obesity and gestational diabetes mellitus
Pantham, P., Aye, I. L. M. H., & Powell, T. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.04.006 · Cited by 582
Effects of maternal obesity on placental function and fetal development
Howell, K. R., & Powell, T. L. (2017) · Reproduction · doi:10.1530/rep-16-0495 · Cited by 347
Maternal obesity and neurodevelopmental and psychiatric disorders in offspring
Edlow, A. G. (2017) · Prenatal Diagnosis · doi:10.1002/pd.4932 · Cited by 308
Christian, L. M., & Porter, K. (2014) · Cytokine · doi:10.1016/j.cyto.2014.06.018 · Cited by 268
Aune, D., Sen, A., Henriksen, T., Saugstad, O. D., & Tonstad, S. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0176-0 · Cited by 170
“Overweight and obesity increases inflammation, flux of free fatty acids, and may thereby lead to insulin resistance [64], which in turn increases the endogenous glucose production in the liver, while physical activity may counteract some of these adverse effects [25, 65].”
BackgroundSelf-citationPathophysiology of Gestational Diabetes Mellitus
Berberoglu, Z. (2019) · EMJ Diabetes · doi:10.33590/emjdiabet/10313616 · Cited by 129
Metadata
- Authors
- Friis, C. M., Paasche Roland, M. C., Godang, K., Ueland, T., Tanbo, T., Bollerslev, J., & Henriksen, T.
- Venue
- Obesity
- Publisher
- Wiley
- Published
- 2013-01
- Volume
- 21
- Issue
- 1
- Pages
- E124-30
- ISSN
- 1930-7381 (ISSN-L)
- 1930-739X
- OpenAlex
- W2023009263
- Cited by
- 104
- References
- 3
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.